Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Stock Symbol
-
BCRX on Nasdaq
Anthony Doyle - trading volume in the past year for Biocryst Pharmaceuticals Inc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
267K |
$1.49M |
$5.57 |
May 14, 2024 |
Direct |
|
|
| Emp. Stock Option (Right to Buy) |
159K |
|
|
Dec 14, 2023 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.